MedPath

Prospective observational study to predict sensitive marker after administration of nintedanib in patients with idiopathic pulmonary fibrosis

Not Applicable
Recruiting
Conditions
Pulmonary fibrosis
Registration Number
JPRN-UMIN000022232
Lead Sponsor
Gunma University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Judgement as exclusion by chief mdical physians Acute crdac infarcton or angina pectoris Candidate for lung transplntation With malignant disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath